Mild Cognitive Impairment & Subjective Cognitive Decline Flashcards
Difference between SCD and MCI
- SCD: The patient thinks there are changes but we can’t see changes on the tests
- MCI: There is a subjective measure for it on a test, but it’s still liveable
Continuum of decline
- The progression through the stages of cognitive decline and dementia
- It is not necessarily linear
- Not guarantee of progression to dementia
- Can be reversed before stage 3
- 10% convert from MCI to dementia annually
Stage 1 of the continuum of decline
- No objective or subjective evidence for cognitive decline or impairment
- No behavioural symptoms
Stage 2 of the continuum of decline
- Subjective or/and subtle objective cognitive decline
- Does not meet criteria for impairment
- Mild, recent onset behavioural symptoms could co-occur or be the predominant symptom
Stage 3 of the continuum of decline
- Objective cognitive decline to the level of impairment and mild functional impairment possible, but independence preserved
Stage 4 of the continuum of decline
- Mild dementia
Stage 5 of the continuum of decline
- Moderate dementia
Stage 6 of the continuum of decline
- Severe dementia
Preclinical dementia
- Subjective cognitive decline
- Perceived deficits in cognition
- No objective deficits in cognition
Aging to Mild Cognitive Impairment
- Declines that are more severe then what is expected for their age and education is considered mild cognitive impairment
- Changes in memory
- Changes in language
- Changes in visuospatial function
- Changes in attention or executive functioning
Aging to MCI to Dementia
- Declines that are more severe then what is expected for their age and education is considered mild cognitive impairment
- Once the declines begin to impede on daily functioning the individual is diagnosed as having dementia
What is MCI
- A condition in which someone experiences cognitive declines beyond what is expected in normal aging
- These declines are severe enough to be noticed by the person and loved ones
- The declines do not affect their ability to carry out everyday activities
- May or may not progress to develop dementia
- Can be reverted back but they have a higher chance of developing AD or dementia
MCI risk factors
- Lower education
- APOE e4 status: allele that is a marker for AD/Dementia
- Increased age
- Family history of AD or dementia
- Conditions associated with cardiovascular disease
MCI Misdiagnosed
- Sometimes MCI can be treated because it’s associated with some underlying condition
- Depression
- Metabolic causes
- Infection causes
- Sleep disorders
- Neurological disorders
- Perceived stress
Cognitive Problems
- Changes in memory
- Changes in language
- Changes in visuospatial function
- Changes in attention/executive function
- Typically we use a cut off of 1.5SD below age and education matched means to show problems
- MoCA and other tests are what we use to evaluate this
MCI Subtypes
- Cognitive tests will determine which subtype of MCI a person has
- Single domain: One cognitive domain impaired
- Multiple domain: Multiple cognitive domains impaired
- Amnestic MCI: Memory is mainly affected
- Non-amnestic MCI: Other cognitive functions are affected
MCI Outcomes by subtype
- Amnestic MCI: AD, Vascular dementia
- Non-amnestic MCI: FTD, Lewy body dementia, Parkinson’s disease dementia
Brain changes in MCI
- Atrophy: Typically see people with MCI having less brain volume compared to normal
- Amyloid buildup: Increases in amyloid deposits throughout the brain
- Tau buildup: Increases in tau, particularly in temporal lobe structure
Progression of MCI to Dementia
- 10 to 15% of individuals with MCI develop dementia each year
- 1/3 of people with MCI develop dementia within 5 years
Factors that increase risk of development from MCI to Dementia
- Older age
- APOE e4 status
- Hippocampal atrophy on structural MRI
- Vascular abnormalities
- Biomarker positivity: Tau and amyloid
Reducing progression from MCI to Dementia
- Treating underlying conditions
- Stopping medications that may be causing cognitive decline
- Non pharmalogic interventions include:
- Regular physical exercise
- A diet in low fat and rich in fruits and vegetables
- Omega 3 fatty acids
- Keeping your brain active
- Being social
Subjective Cognitive Decline (SCD)
- An indicator of declining cognitive function
- Pre clinical dementia
- Self perceived decline in memory and/or other cognitive abilities relative to the previous level of performance, but there is an absence of objective neuropsychological deficits
- Increases likelihood of having biomarker abnormalities consistent with dementia pathology
- Increases risk for future pathological cognitive decline and dementia
Brain changes in SCD
- Atrophy: typically see people with SCD have less brain volume compared to non-SCD older adults increase complaints means more decline in the left and right hippocampi
- Amyloid buildup: Increases in amyloid deposits throughout the brain
- Tau buildup: Increases in tau, particularly in the enthorhinal region
Conversion from SCD to MCI/Dementia
- Twice as likely to develop dementia than those with SCD
- Features that increase likelihood of preclinical AD
- Subject decline in memory rather than in other domains of cognition
- Age at onset of SCD is over 60
- Concerns associated with SCD
- Feeling of performing worse than others of the same age group
- Confirmation of cognitive decline by an informant
- Presence of the APOE e4 genotype
- Biomarker evidence for AD (defines preclinical AD)
Sex differences in dementia
- There are more females diagnosed
- Females exhibit more pathology
- Females show more decline in cognition associated with the same amount of brain changes as males
- Females are more likely to have a faster progression than males
Race differences in dementia
- Black older adults are twice as likely to develop dementia than white adults
- Racial differences exist in prevalence of risk factors
- Some studies suggest black older adults have a faster progression and shorter survival time after diagnosis than white older adults